Literature DB >> 10960783

A direct screen for secreted proteins in Xenopus embryos identifies distinct activities for the Wnt antagonists Crescent and Frzb-1.

E M Pera1, E M De Robertis.   

Abstract

To determine the spectrum of secreted proteins that are present in the extracellular space of early Xenopus embryos, a direct secretion screen was performed. Surprisingly, 24% of previously identified bona fide secretory proteins corresponded to four secreted Wnt antagonists of the same family: frzb-1, sizzled, sfrp-2 and crescent. sfrp-2 and crescent are novel components of the growing cocktail of growth factor antagonists secreted by Spemann organizer cells in Xenopus. Crescent is first expressed at blastula, defining a deep endodermal region that may be homologous to the avian hypoblast. Unlike other members of this family of inhibitors, microinjection of crescent mRNA causes the development of cyclopic embryos, even though the amount of anterior neural tissue is normal. In crescent-injected embryos, studies with specific markers indicate that morphogenetic movements of the anterior midline are abnormal, resulting in a more posterior location of prechordal plate and ventral forebrain markers with respect to the developing eye field. The results are discussed in light of recent findings in zebrafish and Xenopus that suggest that Wnt signaling through non-canonical (non-beta-catenin dependent) pathways plays a pivotal role in the regulation of morphogenetic movements.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10960783     DOI: 10.1016/s0925-4773(00)00394-4

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  34 in total

1.  Inhibition of Wnt activity induces heart formation from posterior mesoderm.

Authors:  M J Marvin; G Di Rocco; A Gardiner; S M Bush; A B Lassar
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

Review 2.  The establishment of Spemann's organizer and patterning of the vertebrate embryo.

Authors:  E M De Robertis; J Larraín; M Oelgeschläger; O Wessely
Journal:  Nat Rev Genet       Date:  2000-12       Impact factor: 53.242

3.  Neural induction in the absence of mesoderm: beta-catenin-dependent expression of secreted BMP antagonists at the blastula stage in Xenopus.

Authors:  O Wessely; E Agius; M Oelgeschläger; E M Pera; E M De Robertis
Journal:  Dev Biol       Date:  2001-06-01       Impact factor: 3.582

Review 4.  Dickkopf1: a tumor suppressor or metastasis promoter?

Authors:  Mitchell E Menezes; Daniel J Devine; Lalita A Shevde; Rajeev S Samant
Journal:  Int J Cancer       Date:  2011-11-02       Impact factor: 7.396

5.  Embryonic dorsal-ventral signaling: secreted frizzled-related proteins as inhibitors of tolloid proteinases.

Authors:  Hojoon X Lee; Andrea L Ambrosio; Bruno Reversade; E M De Robertis
Journal:  Cell       Date:  2006-01-13       Impact factor: 41.582

Review 6.  Transcriptional regulation of cranial sensory placode development.

Authors:  Sally A Moody; Anthony-Samuel LaMantia
Journal:  Curr Top Dev Biol       Date:  2015-01-22       Impact factor: 4.897

7.  Wnt antagonism initiates cardiogenesis in Xenopus laevis.

Authors:  V A Schneider; M Mercola
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

8.  Choice of either beta-catenin or Groucho/TLE as a co-factor for Xtcf-3 determines dorsal-ventral cell fate of diencephalon during Xenopus development.

Authors:  Saori Tsuji; Chikara Hashimoto
Journal:  Dev Genes Evol       Date:  2005-03-04       Impact factor: 0.900

9.  Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.

Authors:  Débora Sinner; Jennifer J Kordich; Jason R Spence; Robert Opoka; Scott Rankin; Suh-Chin J Lin; Diva Jonatan; Aaron M Zorn; James M Wells
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

Review 10.  Establishing the pre-placodal region and breaking it into placodes with distinct identities.

Authors:  Jean-Pierre Saint-Jeannet; Sally A Moody
Journal:  Dev Biol       Date:  2014-02-24       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.